Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Only two per cent of child drug trials have independent safety checks

Only two per cent of child drug trials have independent safety checks

March 19, 2008

Only two per cent of paediatric drug trials reported using independent safety monitoring committees that can help lead to the early detection of adverse drug reactions, according to a major review published in the journal Acta Paediatrica.

Child health researchers from The University of Nottingham carried out a detailed analysis of 739 international drug trials published between 1996 and 2002, to see what safety measures were in place to monitor levels of adverse drug reactions.




While 74 per cent of the drug trials described how safety monitoring was performed during the study, only two per cent - 13 studies out of 739 - had independent safety monitoring committees.

Lead author Dr Helen Sammons, an Associate Professor of Child Health in the University's Academic Division of Child Health, based at Derbyshire Children's Hospital, said: "We were very surprised by the low level of trials that had independent safety monitoring committees and are urging pharmaceutical companies to include these in all future trials involving children.

"It is essential that drugs are developed for use in children and clinical trials need to continue. They are vital because they increase the chance of picking up adverse reactions before drugs are introduced into general clinical practice."

Dr Sammons and her colleagues found that:

· Seven out of ten trials reported adverse events and a fifth of the trials reported a serious adverse event, ie. an untoward medical occurrence, not necessarily related to a drug.

· Adverse drug reactions were reported in just under 37 per cent of trials, with 11 per cent of trials reporting moderate or severe adverse drug reactions.

· Six clinical trials - which all had safety monitoring committees - were terminated early because of significant drug toxicity.

· Deaths were reported in 11 per cent of the trials, but the majority were thought to be unrelated to the drug use.

· Death rates were highest in trials involving newborn babies, with 56 per cent of the 99 trials included reporting a death.

· Other major specialities in which deaths were reported included infectious diseases, neurology, respiratory and kidney problems.

Only papers published in English on the Medline database during the seven-year study period were included and the authors excluded studies that covered HIV and cancer because of high deaths rates from the actual diseases.

Just over half of the studies compared a drug with a placebo - dummy - and a further 35 per cent involved a new medicine. A smaller percentage, 26 per cent, involved a direct comparison between two established drugs. Some of the trials included adults as well as children.

Studies reporting severe drug toxicity problems came from a wide range of countries, including Argentina, Belgium, Canada, Chile, China, France, India, Israel, Italy, Japan, Netherlands, South Africa, Sweden, Taiwan, Thailand, Turkey, UK and the USA.

Adverse drug reactions included bleeding, high blood pressure, seizures, psychosis, suicide, acute renal failure and death.

The researchers stress that clinical drug trials in children are essential for the development of medicines and to provide evidence of the best treatments for specific conditions. But they feel that greater safety measures and awareness of the risk is essential.

"We need to test drugs on children as the only other options are to use unlicensed drugs or prescribe drugs that have been licensed for adults off-label - outside the terms of their licence," said Dr Sammons.

"But we feel that the small number of studies that reported having safety monitoring committees was unacceptable. It is invaluable to have an independent monitor who can swiftly question any adverse drug reactions or differences in illness and death rates between groups taking part in the clinical trials.

"Parents also need to be made aware of the risks of adverse drug reactions when a child takes any medicine so that they can make informed decisions that balance those risks against the possible benefits the drug may provide their child.

"In a drug trial this should include information on the mechanisms that will be used during the clinical trial to safeguard the children taking part."

Dr Sammons points out that the number of paediatric drug trials is likely to rise in the European Union, following new legislation that provides pharmaceutical companies with a valuable financial incentive - a six-month extension to their exclusive manufacturing licence for a drug if children are included in the clinical trials. Similar legislation has been in place in the USA for over five years and has led to an increase in drug trials that include children.

She added: "There is general agreement by paediatric health professionals, regulatory authorities and the pharmaceutical industry, as well as politicians and parents, that drug trials are essential in order to improve drug therapies.

"We are calling for all paediatric drug trials to include independent safety monitoring committees to ensure that this vital work is carried out in a way that minimises risks, and maximises benefits, for the children taking part."

The University of Nottingham



Related Drug Trials Current Events and Drug Trials News Articles Drug Trials Current Events and Drug Trials News RSS Drug Trials Current Events and Drug Trials News RSS
Geneticists Hunt for Scleroderma Triggers
At its most benign, the autoimmune disease scleroderma can discolor parts of the skin of its sufferers. At its most pernicious, it can thicken and harden their skin, their blood vessels, and their internal organs before, in many cases, killing them.

New Paper from Internists Calls for Increased Role for FDA
A new policy paper that calls for broader authority and increased funding for the Food and Drug Administration (FDA) was released today by the American College of Physicians (ACP). Improving FDA Regulation of Prescription Drugs offers a half-dozen recommendations about how to improve the agency's ability to approve and monitor new drugs.

Participants in antidepressant drug trials are atypical patients, UT Southwestern researchers report
One reason antidepressant medication treatments do not work as well in real life as they do in clinical studies could be the limited type of study participants selected, researchers at UT Southwestern Medical Center have found.

Researchers Isolate Protein Domain Linked to Tumor Progression
When a promising cancer drug reached clinical trials in the 1990s, researchers were disappointed by the debilitating side effects that limited the trials. The drug inhibited a family of enzymes known as matrix metalloproteinases (MMPs).

Research exposes the risk to infants from the chemicals used in liquid medicines
A team of medical scientists from the University of Leicester has published research which looks into the harmful substances in liquid medicines that premature babies are being exposed to.

Biomedical researchers create artificial human bone marrow in a test tube
Artificial bone marrow that can continuously make red and white blood cells has been created in a University of Michigan lab.

Genes determine whether sugar pills work
It is a well-known fact in drug trials that individuals can respond just as well to placebos, sugar pills, as to the active drug.

Credit crunch threatens new medicines
The global financial crisis could seriously delay the discovery and production of many new life-saving medicines, warns a major international conference today.

Family therapy helps relieve depression symptoms in bipolar teens
Family-focused therapy, when combined with medication, appears effective in stabilizing symptoms of depression among teens with bipolar disorder, according to a report in the September issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

PET scans may help assess presence of brain plaques related to Alzheimer's disease
A type of positron emission tomography (PET) scanning may be useful in a non-invasive assessment of the formation of Alzheimer's disease-related plaques in the brain, according to small study posted online today that will appear in the October 2008 print issue of Archives of Neurology, one of the JAMA/Archives journals.
More Drug Trials Current Events and Drug Trials News Articles
The Drug Trial: Nancy Olivieri and the Science Scandal that Rocked the Hospital for Sick Children

The Drug Trial: Nancy Olivieri and the Science Scandal that Rocked the Hospital for Sick Children
by Miriam Shuchman (Author)

Winner of the Writers' Trust of Canada's Shaughnessy Cohen Prize for Political Writing and the Canadian Science Writers' Association's Science in Society Book Award.

Poison-pen letters, possible medical misconduct and a swirl of competing accusations that led to two inquiries – the Olivieri affair ended careers and shook the international research establishment. A riveting anatomy of Canada’s most controversial drug trial, by the medical journalist who helped break the story.

In August 1998, a medical scandal erupted in the national and international media whose consequences still reverberate. A charismatic young doctor named Nancy Olivieri, working with young people who suffered from a rare blood disorder, stated that she had discovered serious problems with an...

The Trials of Ted Haggard

The Trials of Ted Haggard

A documentary by Alexandra Pelosi takes a behind-the-scenes look at a recent life and hard times of ex-minister, Pastor Ted. Ted Haggard had it all: prosperity, a doting wife, five kids- and a ministry that reached out to approx 30 million followers who counted on his every word, whether on TV or in person at one of his arena sermons. In 2006, it all fell apart when Pastor Ted admitted to having sex with a male prostitute and to buying methamphetamines. He was exiled from his church and home in Colorado and became a pariah who now makes ends meet as a traveling insurance salesman.

This disc is expected to play back in DVD Video "play only" devices, and may not play in other DVD devices, including recorders and PC drives.

This product is manufactured on demand using DVD-R recordable...

Songs for Parents Who Enjoy Drugs

Songs for Parents Who Enjoy Drugs
by Hamell on Trial

On Songs for Parents Who Enjoy Drugs, Hamell on Trial uses his father-son relationship to address the American machine with a stellar blend of bold lyricism and candid politics. "This album is for all those liberal-minded people who can’t fathom raising a child in this world of non-tolerance," explains Ed Hamell, otherwise known as the string-punishing, acoustic punk minstrel Hamell On Trial.

On his second LP for Righteous Babe Records, Hamell gets in touch with his outer child right before our ears. Newfound fatherhood is the inspiration here: Hamell’s three-year-old son, Detroit, is all over the album, as a character in his dad’s lyrics and as a guest vocalist. And the one-man-punk-band is expanded with the help of a few friends (Andrew Case on drums, Mike Napolitano on...

The Cure

The Cure
Also With: J.J. Abrams (Producer), Alex Kurtzman (Producer), Roberto Orci (Producer), Jeff Pinkner (Producer), Bryan Burk (Producer)



The Drug Trial: Nancy Olivieri and the Science Scandal That Rocked the Hospital for Sick Children by Miriam Shuchman

The Drug Trial: Nancy Olivieri and the Science Scandal That Rocked the Hospital for Sick Children by Miriam Shuchman
by Random House of Canada

Poison-pen letters, possible medical misconduct and a swirl of competing accusations that led to two inquiries the Olivieri affair ended careers and shook the international research establishment. A riveting anatomy of Canada's most controversial drug trial, by the medical journalist who helped break the story. In August 1998, a medical scandal erupted in the national and international media whose consequences still reverberate. A charismatic young doctor named Nancy Olivieri, working with young people who suffered from a rare blood disorder, stated that she had discovered serious problems with an experimental drug manufactured by Canada's largest drug company, Apotex. Though her research contract required her to remain silent, she decided she had no choice but to warn the patients...

Vent Professional Trial & Travel Brush, 4 Pieces

Vent Professional Trial & Travel Brush, 4 Pieces
by LIL DRUG STORE .

INDICATIONS: Vent Professional Trial & Travel Brush.

Songs for Parents Who Enjoy Drugs

Songs for Parents Who Enjoy Drugs
Hamell On Trial (Primary Contributor)



RED DAWN SPARK 20 1 Gram

RED DAWN SPARK 20 1 Gram
by ZEdgeCollectibles.com

Red Dawn SPARK 20 1 Gram - Extreme Aromatic Pleasure

Clinical Drug Trials And Tribulations, Revised And Expanded (Drugs and the Pharmaceutical Sciences)

Clinical Drug Trials And Tribulations, Revised And Expanded (Drugs and the Pharmaceutical Sciences)
by Cato (Author)

Presents the latest information on drug development with new material on international regulation and deregulation, venture capitalist investment, the IND process, informed consent, and more. Previous edition: c1988.

Red Dawn Vector Pill 1 Pill

Red Dawn Vector Pill 1 Pill
by Red Dawn

Red Dawn Vector Pill. Contains 1 Pill. Mass Quanity Available, check my other listings. DIRECTIONS: Take one Vector about one hour before desired results. Effects vary from person to person. DO NOT take more than one tablet within a 24 hour period. DESCRIPTION: Vector® Pill is Extreme Bliss... Designed to amp up your party, this is a true experience for the club or social environment... Warning: Vector may cause sensitivity to touch or extreme pleasure. Vector is great for both men & women... WARNING: WARNING: DO NOT DRIVE OR OPERATE HEAVY MACHINERY WHILE USING THIS PRODUCT. This product is not for sale to persons under the age of 18. This Dietary supplement should not be taken by people who are sensitive to herbal products. Do not use if you are pregnant or nursing, have high blood...

© 2009 BrightSurf.com